# Evaluation of a Novel Insulin Sensitizer in People With Type 1 Diabetes

> **NCT07186660** · PHASE2 · RECRUITING · sponsor: **University of Virginia** · enrollment: 40 (estimated)

## Conditions studied

- Type 1 Diabetes (T1D)
- Glycemic Control for Diabetes Mellitus
- Insulin
- Ketones
- Cardiovascular Health

## Interventions

- **DRUG:** CIR-0602K
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07186660
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-22
- **Primary completion:** 2028-09
- **Final completion:** 2028-09
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07186660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07186660, "Evaluation of a Novel Insulin Sensitizer in People With Type 1 Diabetes". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT07186660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*